Editas Medicine, Inc. (NASDAQ:EDIT) Jumps in Trading Today – Up by 4.09% – Modern Readers
|
Editas Medicine, Inc. (NASDAQ:EDIT) Jumps in Trading Today – Up by 4.09%
Modern Readers CRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme, including either Cas9 (CRISPR associated protein 9) or Cpf1 (CRISPR from Prevotella and Francisella 1), bound to a guide RNA molecule designed to recognize a particular … |
